Researchers noted that deficits in temporal pain inhibition were associated with a higher intensity of knee pain and ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Knee Osteoarthritis Clinical ...

The PPV-06 vaccine was safe, immunogenic, and linked with functional improvement at 42 weeks in a phase 1 trial of inflammatory knee osteoarthritis.

The first patients in the world have been treated with Scarcell Therapeutics' aGF Therapy using gum cells designed to relieve ...

A comprehensive analysis of 217 trials involving over 15,000 participants revealed that aerobic exercises like walking, ...

Knee braces and water-based exercise appear to be two of the most effective ways to ease the pain and stiffness caused by knee osteoarthritis. That is according to a review of 12 non-drug therapies, ...

Cipla partners with Stempeutics to launch Ciplostem, a new therapy for Knee Osteoarthritis approved by DCGI. Targets disease ...

A new clinical study aims to explore how customized foot orthoses can enhance knee alignment, reduce pain, and improve ...

Approved by the Drug Controller General of India (DCGI), the treatment offers to slow disease progression and promote ...

Cipla and Stempeutics launch Ciplostem, a DCGI-approved cell therapy for Grade II–III Knee Osteoarthritis, offering long-term ...

An Osaka Metropolitan University-led research team found that patients with knee osteoarthritis show a weaker human-body ...

Pilot program addresses critical evidence gap in emerging regenerative medicine treatments for 32.5 million Americans with ...